TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
GHN Pharma AB
Closing information (x1000 EUR)
| Closing information | 2024/12 (consolidated) | 2023/12 | 2022/12 |
| Turnover |
14,101
|
180
|
27 |
| Financial expenses |
15
|
1
|
219 |
| Earnings before taxes |
2,537
|
477
|
-267 |
| EBITDA |
1,760
|
-5
|
-181 |
| Total assets |
14,937
|
8,611
|
8,143 |
| Current assets |
6,153
|
268
|
216 |
| Current liabilities |
2,720
|
76
|
19 |
| Equity capital |
11,393
|
8,535
|
8,124 |
| - share capital |
36
|
37
|
37 |
| Employees (average) |
7
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 | 2022/12 |
| Solvency |
76.3%
|
99.1%
|
99.8% |
| Turnover per employee |
2,014
|
90
|
14 |
| Profit as a percentage of turnover |
18.0%
|
265.0%
|
-988.9% |
| Return on assets (ROA) |
17.1%
|
5.6%
|
-0.6% |
| Current ratio |
226.2%
|
352.6%
|
1136.8% |
| Return on equity (ROE) |
22.3%
|
5.6%
|
-3.3% |
| Change turnover | |||
| Change turnover % |
575%
|
-95% | |
| Chg. No. of employees | |||
| Chg. No. of employees % |
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.